[Whitepaper] What You Need to Know to Avoid Costly Delays in Your API Scale-Up

Drug developers must be prepared to react to changes in their API’s quality attributes, even if the synthesis used at a small scale is the same one used at a large scale.

If undesirable effects occur that negatively impact API scale-up, it can prevent a company from delivering a product with reliable quality and efficacy.


Sponsored by: